Disentangling the heterogeneity of autism spectrum disorder through genetic findings

By Shafali S. Jeste, Daniel H. Geschwind. Nature Reviews Neurology, 2014

637 citations recorded by the source corpus.

Autism spectrum disorder (ASD) represents a heterogeneous group of disorders, which presents a substantial challenge to diagnosis and treatment. Over the past decade, considerable progress has been made in the identification of genetic risk factors for ASD that define specific mechanisms and pathways underlying the associated behavioural deficits. In this Review, we discuss how some of the latest advances in the genetics of ASD have facilitated parsing of the phenotypic heterogeneity of this disorder. We argue that only through such advances will we begin to define endophenotypes that can benefit from targeted, hypothesis-driven treatments. We review the latest technologies used to identify and characterize the genetics underlying ASD and then consider three themes—single-gene disorders, the gender bias in ASD, and the genetics of neurological comorbidities—that highlight ways in which we can use genetics to define the many phenotypes within the autism spectrum. We also present current clinical guidelines for genetic testing in ASD and their implications for prognosis and treatment.

Subfields: Cognitive Neuroscience, Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/a8895d90524ee4e609b91864bc81c29e6957ae85

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cognitive Neuroscience

  1. Waldemar Karwowski
  2. Farzad Vasheghani Farahani
  3. David S. Grayson
  4. Nichole R. Lighthall
  5. Damien A. Fair
  6. Olaf Sporns
  7. Steven E. Petersen

In Molecular Biology

  1. Waldemar Karwowski
  2. Farzad Vasheghani Farahani
  3. Nichole R. Lighthall
  4. Damien A. Fair

Citations in the corpus